Advertisement

Topics

Search Results for "Apatinib"

09:47 EDT 22nd October 2017 | BioPortfolio

Original Source: Cholangiocarcinoma

Matching Channels

None

Matching News

Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma

LSK BioPartners Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23082017] Prices from USD $250

SummaryLSK BioPartners Inc LSK BioPartners dba LSK BioPharma is a biopharmaceutical company which develops therapies for unmet medical needs in cancer. The company is developing proprietary drug candi...

Matching PubMed Articles

Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma.

The cure rate of osteosarcoma has not improved in the past 30 years. The search for new treatments and drugs is urgently needed. Apatinib is a high selectivity inhibitor of vascular endothelial growth...

Pharmacokinetic Drug Interactions of Apatinib With Rifampin and Itraconazole.

Apatinib is a small-molecule tyrosine kinase inhibitor that has been approved for the treatment of patients with advanced-stage gastric cancer or gastroesophageal junction cancer who have progressed o...

Concurrent apatinib and local radiation therapy for advanced gastric cancer: A case report and review of the literature.

Apatinib is a novel anti-angiogenic agent targeting vascular endothelial growth factor receptor-2, which is effective in patients with chemotherapy-refractory gastric cancer. There are no reports of c...

Case report of apatinib mesylate treatment in rare advanced tracheal adenoid cystic carcinoma.

A 57-year-old man was admitted to our department 10 years ago, diagnosed with tracheal adenoid cystic carcinoma. After discontinuing chemotherapy and radiotherapy, the disease recurred in December 2...

Overwhelming rapid metabolic and structural response to apatinib in radioiodine refractory differentiated thyroid cancer.

Currently, patients with radioiodine refractory differentiated thyroid cancer (RAIR-DTC) have limited treatment options. In this study, we aimed to assess the short-term efficacy and safety of apatini...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement